Sermorelin vs Ipamorelin vs CJC-1295: Which Peptide Is Best?

I spent six months trying to figure out which growth hormone peptide to start with. Sermorelin had FDA history behind it. Ipamorelin was supposedly the “cleanest” option. CJC-1295 promised the strongest results. Every article I read made a different recommendation, and most of them were obviously written by people who had never actually used any of these peptides.

So I tried all three. Not at once, obviously. I ran sermorelin first for 12 weeks, then ipamorelin for another 12, then a CJC-1295/ipamorelin stack. I tracked sleep with an Oura ring, got bloodwork done before and after each cycle, and kept detailed notes on subjective effects.

Here’s what I actually learned: they all work, but they work differently. The “best” one depends entirely on what you’re optimizing for, how much you want to inject, and how your body responds. This guide breaks down everything I wish I’d known before starting.

What Are Growth Hormone Secretagogues?

Before we get into the comparisons, the basics matter. Growth hormone secretagogues are peptides that stimulate your pituitary gland to produce more growth hormone naturally. They’re not synthetic HGH. They’re signals that tell your body to make more of its own GH.

This distinction matters. When you inject synthetic HGH, you’re adding external hormone to your system. Your pituitary notices and can downregulate its own production. With secretagogues, you’re working with your body’s existing machinery. The pituitary still controls the release, which means you maintain natural pulsatile patterns and feedback loops.

There are two main categories of secretagogues. GHRH analogs (like sermorelin and CJC-1295) mimic growth hormone-releasing hormone, the signal your hypothalamus sends to trigger GH release. GHRPs (like ipamorelin) work through the ghrelin receptor, a completely different pathway that also triggers GH release but through different mechanisms.

Why does this matter? Because combining both pathways creates synergistic effects. More on that later.

Related: Andrew Huberman on Peptides: Complete Guide to Benefits, Risks & Personal Experiences

What Is Sermorelin?

Sermorelin is the OG of growth hormone peptides. It’s a 29-amino acid synthetic version of the first portion of human GHRH. When you inject it, it binds to GHRH receptors on your pituitary and triggers the same cascade that natural GHRH would: adenylyl cyclase activation, increased cAMP, and ultimately GH release.

The FDA approved sermorelin (brand name Geref) back in 1997 for diagnosing and treating growth hormone deficiency in children. It was voluntarily discontinued by the manufacturer EMD Serono in 2008. Not because of safety issues or lack of efficacy. Supply chain difficulties. The FDA formally confirmed this in March 2013, which is why compounding pharmacies can still legally make it. A 2006 clinical review argued sermorelin may actually be a better option than synthetic HGH for aging adults because of its safety profile and physiological release patterns.

That FDA history is meaningful. It means sermorelin went through actual clinical trials. We have real safety data, not just “research chemical” speculation.

Key Research on Sermorelin

The Corpas study from 1992 showed that high-dose sermorelin elevated mean 24-hour GH and increased IGF-1 by approximately 25% in elderly men. Their levels approached those of younger untreated men. The Khorram study in 1997 ran a 16-week randomized controlled trial and found significant increases in nocturnal GH, serum IGF-1, and lean body mass (men gained an average of 1.26 kg). They also saw measurable increases in skin thickness.

Vittone’s 6-week study showed sermorelin nearly doubled 12-hour mean GH release while keeping levels within physiological norms. That last part is important. You’re not spiking GH to supraphysiological levels. You’re restoring more youthful patterns.

Sermorelin Pros

• FDA approval history with established safety data
• Produces natural, pulsatile GH release
• Preserves hypothalamic-pituitary feedback
• Overdose is “difficult if not impossible” (self-limiting)
• Legal pathway through compounding pharmacies
• Generally the most affordable option

Sermorelin Cons

• Very short half-life (10-12 minutes)
• Low bioavailability (~6% subcutaneous)
• About 70% of users develop anti-GRF antibodies (usually clinically insignificant)
• 6.5% incidence of hypothyroidism during therapy (monitor thyroid function)
• Results can be subtle compared to stronger options

For sourcing, I get my sermorelin from Limitless Life Nootropics in 5mg vials. They’re US-based, third-party test every batch for 99%+ purity, and ship same-day. With the BRAINFLOW code you’re looking at around $40-50 per vial after the 15% discount.

What Is Ipamorelin?

Ipamorelin is a pentapeptide that works through an entirely different mechanism than sermorelin. Instead of mimicking GHRH, it mimics ghrelin and binds to the growth hormone secretagogue receptor (GHS-R1a). Same end result (GH release), different pathway to get there.

What makes ipamorelin special is its selectivity. The landmark 1998 Raun study in the European Journal of Endocrinology demonstrated that ipamorelin did not increase ACTH or cortisol even at doses 200 times higher than the dose needed for maximum GH release. That’s remarkable. Other GHRPs like GHRP-6 and GHRP-2 increase cortisol, prolactin, and appetite. Ipamorelin doesn’t.

This selectivity comes from its unique molecular structure. The alpha-aminoisobutyric acid at position 1 and D-amino acids create a conformation that targets only GH-releasing pathways. No cortisol spikes that cause muscle breakdown. No prolactin increases that cause sexual dysfunction. No ravenous hunger that GHRP-6 is notorious for.

Key Research on Ipamorelin

The 1999 Gobburu pharmacokinetic study in healthy males established dose-response relationships. Helsinn Therapeutics ran Phase II trials that demonstrated safety with no serious adverse events. The trials failed to show efficacy for their primary endpoint (postoperative ileus recovery), but that’s a very specific application. Development was discontinued for that indication, not because of safety concerns.

The evidence base is smaller than sermorelin’s, but what exists is favorable. And the mechanistic data on selectivity is solid.

Ipamorelin Pros

• Cleanest side effect profile of any growth hormone peptide
• No cortisol or prolactin increases
• No appetite stimulation (unlike GHRP-6)
• Longer half-life than sermorelin (~2 hours)
• Doesn’t cause receptor desensitization like hexarelin
• Excellent for stacking with GHRH analogs

Ipamorelin Cons

• Never FDA-approved (regulatory uncertainty)
• Limited clinical trial data compared to sermorelin
• Less potent GH release than some alternatives when used alone
• Optimal results require multiple daily injections or stacking

I source my ipamorelin from Limitless Life Nootropics. They offer both 5mg and 10mg vials at 99% purity with third-party COAs. The 10mg option is more cost-effective if you’re running a full cycle. Use code BRAINFLOW for 15% off.

Related: 4 Best Peptides for Anti-Aging

What Is CJC-1295?

CJC-1295 is where things get a bit confusing because there are actually two different peptides sold under this name. You need to know which one you’re getting.

CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF) is a tetrasubstituted GHRH analog. Four amino acid changes increase its half-life from about 7 minutes (native GHRH) to approximately 30 minutes. It’s still relatively short-acting and produces pulsatile GH release similar to natural patterns.

CJC-1295 with DAC includes a Drug Affinity Complex, a maleimidopropionyl moiety that covalently binds to serum albumin within 15 minutes of injection. This extends the half-life dramatically to 6-8 days. One injection keeps GH elevated for almost a week.

The Teichman study published in the Journal of Clinical Endocrinology & Metabolism in 2006 tested CJC-1295 with DAC in healthy adults. Single doses of 30-60 μg/kg were “safe and relatively well tolerated.” A single injection raised plasma GH levels 2-10 fold for 6 or more days, with IGF-1 remaining elevated for 9-11 days.

That’s powerful. But continuous GH elevation isn’t necessarily better. Natural GH release is pulsatile for a reason. The body responds differently to constant versus intermittent signals.

CJC-1295 Pros (No DAC Version)

• More potent than sermorelin
• Maintains natural pulsatile GH patterns
• Excellent synergy when stacked with ipamorelin
• 30-minute half-life allows for timed dosing

CJC-1295 Pros (DAC Version)

• Convenient once or twice weekly dosing
• Sustained GH and IGF-1 elevation
• Fewer injections overall
• Documented human clinical trial data

CJC-1295 Cons

• Never FDA-approved
• Phase II trial halted after patient death (attributed to pre-existing coronary disease, not the peptide)
• December 2024 FDA advisory committee recommended against 503A compounding
• DAC version’s long half-life means side effects persist if problems occur
• Immunogenicity concerns (antibody development)
• Some reports of tachycardia and arrhythmias

If you’re going the stack route, Limitless sells a pre-blended CJC-1295 (no DAC) + Ipamorelin in a 1:1 ratio. Saves you from buying two separate vials and doing the math yourself. Same 99% purity standard, same third-party testing. Code BRAINFLOW knocks 15% off.

Sermorelin vs Ipamorelin vs CJC-1295: Side-by-Side Comparison

Here’s how these three peptides stack up across the metrics that actually matter:

Feature	Sermorelin	Ipamorelin	CJC-1295 (no DAC)	CJC-1295 (DAC)
Mechanism	GHRH analog	Ghrelin mimetic (GHRP)	GHRH analog	GHRH analog
Half-life	10-12 minutes	~2 hours	~30 minutes	6-8 days
Dosing frequency	Once daily	1-3x daily	1-3x daily	1-2x weekly
GH release pattern	Pulsatile	Pulsatile	Pulsatile	Sustained
FDA history	Previously approved	Never approved	Never approved	Never approved
Cortisol increase	Minimal	None	Minimal	Minimal
Prolactin increase	None	None	None	None
Appetite increase	None	None	None	None
Best for stacking	Yes (with GHRPs)	Yes (with GHRH)	Yes (with ipamorelin)	Not recommended
Relative potency	Moderate	Moderate	High	Highest
Monthly cost	$150-350	$200-400	$200-400	$200-600

Key Differences Explained

The fundamental split is between GHRH pathway (sermorelin, CJC-1295) and ghrelin pathway (ipamorelin). This isn’t just academic. These pathways have different effects on the pituitary.

GHRH analogs increase the number of somatotroph cells releasing GH. GHRPs increase the amount of GH released per cell. When you combine both, you get synergy: more cells releasing more hormone each. Studies show this produces “enormous synergistic effect” rather than merely additive results.

The half-life differences drive dosing strategy. Sermorelin’s 10-minute half-life means it’s in and out quickly. One bedtime dose works because you’re amplifying the natural nocturnal GH pulse. CJC-1295 with DAC’s week-long half-life means you’re maintaining constant elevation, which may cause receptor adaptation over time.

Ipamorelin’s selectivity is its defining feature. If you’re worried about side effects, particularly cortisol-related issues like muscle catabolism or metabolic dysfunction, ipamorelin is the conservative choice.

Which Peptide Should You Choose?

Choose Sermorelin If:

• You want the safest option with the most regulatory history
• You’re working with a traditional anti-aging clinic that prefers FDA-history compounds
• You want a gentle introduction to peptide therapy
• Budget is a consideration (often the cheapest option)
• You’re a woman going through perimenopause or menopause (well-studied in this population)

Choose Ipamorelin If:

• Side effect profile is your top priority
• You’re concerned about cortisol or prolactin effects
• You want to avoid appetite stimulation while optimizing GH
• You’re primarily interested in sleep improvement and recovery
• You plan to eventually stack with a GHRH analog
• You’re new to peptides and want to see how you respond

Choose CJC-1295 (No DAC) If:

• You want maximum GH release while maintaining natural patterns
• You’re planning to stack with ipamorelin for synergistic effects
• You’ve tried sermorelin and want something more potent
• You’re focused on body composition changes (fat loss, muscle gain)

Choose CJC-1295 (With DAC) If:

• Injection frequency is your main concern
• You travel frequently and can’t maintain daily protocols
• You want sustained rather than pulsatile GH elevation
• You understand and accept the regulatory uncertainty

The Case for Stacking: CJC-1295 + Ipamorelin

The CJC-1295 (no DAC) plus ipamorelin combination has become the most popular peptide stack for good reason. You’re hitting both pathways simultaneously, and the math works out favorably.

Here’s what happens mechanistically: ipamorelin suppresses somatostatin at both hypothalamic and pituitary levels. Somatostatin is the hormone that inhibits GH release. It’s like the brake pedal. By releasing that brake, you allow the GHRH analog (CJC-1295) to work more effectively. Research confirms that in cell cultures, these peptides show only additive effects. In living systems, they demonstrate synergy. The difference is somatostatin suppression, which only happens in vivo.

The standard stacking protocol uses a 1:1 ratio. Beginners typically start at 100 mcg of each, once daily before bed, five days on and two days off. Standard protocols run 200 mcg of each. Advanced users might go to 300 mcg of each, sometimes splitting into morning and evening doses.

Why not stack with CJC-1295 with DAC? The continuous release conflicts with the pulsatile approach. The whole point of synchronized timing is creating amplified pulses. A peptide with a week-long half-life can’t coordinate with that.

Related: GLOW Peptide Benefits & Dosage Guide (another popular peptide blend)

Dosing Protocols

Sermorelin Dosing

Standard range is 100-500 mcg daily, with 200-300 mcg being the common sweet spot. Timing matters: inject 30-60 minutes before bedtime on an empty stomach. You want to amplify your natural nocturnal GH pulse, not fight against a post-meal insulin spike.

Cycle length typically runs 8-16 weeks. Some practitioners allow continuous use given the self-limiting nature of the mechanism. The pituitary won’t release GH beyond physiological limits regardless of how much sermorelin you inject.

Ipamorelin Dosing

Per injection: 100-300 mcg, with 200-300 mcg most common. Frequency ranges from once daily (beginners) to three times daily (advanced). The saturation dose concept applies here: at approximately 100 mcg (or 1 mcg/kg body weight), receptor occupancy reaches maximum efficiency. Going above 300 mcg shows diminishing returns.

Critical timing note: empty stomach is essential. Insulin from food significantly blunts GH release. Wait at least 2 hours after eating, and don’t eat for 30-60 minutes after injection.

CJC-1295 (No DAC) Dosing

Per injection: 100-300 mcg. Frequency: 1-3 times daily due to the 30-minute half-life. Most commonly paired with ipamorelin in a 1:1 ratio. Same fasting requirements as ipamorelin.

CJC-1295 (With DAC) Dosing

Weekly dose: 1-2 mg (1000-2000 mcg). Frequency: once weekly to twice weekly. Not typically stacked due to continuous release pattern. The long half-life makes timing less critical, but most people inject on the same day each week for consistency.

Stack Dosing (CJC-1295 No DAC + Ipamorelin)

Level	CJC-1295 (no DAC)	Ipamorelin	Frequency
Beginner	100 mcg	100 mcg	Once daily (bedtime), 5 days on/2 off
Standard	200 mcg	200 mcg	Once daily (bedtime), 5 days on/2 off
Advanced	300 mcg	300 mcg	Split AM/PM dosing

What to Expect: Results Timeline

Fair warning on expectations: these aren’t steroids. You’re not going to wake up jacked after a week. The changes are gradual and cumulative.

Weeks 1-2: Sleep improvements are typically the first thing people notice. Deeper sleep, more vivid dreams, feeling more refreshed upon waking. I noticed this around day 5 on ipamorelin. Subtle mood improvements and slightly better recovery from workouts.

Weeks 2-4: Better energy levels, especially in the afternoon when you’d normally hit a wall. Improved recovery from exercise. Clearer thinking. Reduced afternoon energy crashes.

Weeks 4-8: Subtle body composition changes beginning. Muscle tone starts improving. Skin may look slightly better. Joints feel smoother. This is around when my wife first commented that I looked different.

Months 2-3: Visible fat loss, particularly stubborn areas like lower belly. Sharper muscle definition. Improved skin elasticity. Libido improvements for many people.

Months 3-6: The compounding effects become obvious. Significant body composition changes. Major improvements in how you look and feel. Hair and nail growth acceleration. This is when people start asking what you’re doing differently.

Safety and Side Effects

Common Side Effects (All Three)

• Injection site reactions (redness, irritation, itching)
• Transient facial flushing (more common with sermorelin)
• Headache (usually mild and resolves quickly)
• Water retention (typically transient)
• Numbness or tingling in extremities

Sermorelin-Specific Considerations

About 70% of users develop anti-GRF antibodies. Sounds scary, but these typically have no clinical significance. More concerning is the 6.5% incidence of hypothyroidism during sermorelin therapy. Get your thyroid function tested before starting and monitor periodically.

CJC-1295 Specific Considerations

The DAC version raises the most safety concerns. The December 2024 FDA PCAC meeting recommended against placing CJC-1295 on the 503A Bulks List, citing immunogenicity concerns, cardiovascular effects (including tachycardia and arrhythmias), and limited human clinical data. The very long half-life means that if you do experience problems, you’re stuck with them for days.

Who Should Avoid These Peptides

• Anyone with active cancer or recent malignancy (GH and IGF-1 can promote tumor growth)
• Pregnant or breastfeeding women
• People with critical illness
• Those with uncontrolled diabetes (GH antagonizes insulin)
• People with existing pituitary conditions
• History of brain tumors

As Andrew Huberman has noted, peptides “act broadly. You will activate additional pathways, regardless of the intended target.” He strongly advises avoiding peptides with any cancer history because “growth hormone and IGF-1 are indiscriminate in terms of tissue they promote the growth of.”

Legal Status (Updated December 2024)

The regulatory situation is complex and actively evolving. Here’s the current status:

Sermorelin has the clearest legal pathway. Though brand-name Geref was discontinued, the FDA confirmed in 2013 it was not withdrawn for safety or efficacy reasons. It remains legally compoundable under Section 503A of the Food, Drug, and Cosmetic Act with a valid prescription. It is not a DEA-controlled substance.

Ipamorelin and CJC-1295 are in regulatory flux. Neither has ever been FDA-approved for human use. The FDA added both to Category 2 of the “Bulk Drug Substances that Raise Significant Safety Risks” list in late 2023, effectively prohibiting compounding. In September 2024, both were removed from Category 2 pending further PCAC review. This reopened evaluation but does not mean approval.

Currently, these peptides can be purchased as “research chemicals” with “For Research Use Only” labels. Marketing them for human use violates federal law. Many anti-aging clinics have pivoted to sermorelin and FDA-approved tesamorelin as their primary options.

All three peptides are prohibited by WADA and banned at all times for athletes subject to anti-doping testing.

Where to Buy These Peptides

Getting your hands on quality peptides depends on which one you’re after and your access to medical supervision.

Sermorelin has the easiest legal pathway. Since the FDA confirmed its discontinuation was for business reasons (not safety), compounding pharmacies can legally produce it under Section 503A. You’ll need a prescription from a licensed provider. Many anti-aging and longevity clinics offer sermorelin as part of their hormone optimization protocols. Telehealth platforms have made this more accessible, though you’ll still need bloodwork and a consultation.

Ipamorelin and CJC-1295 are trickier. They’ve never had FDA approval, so they can’t be legally marketed for human use. You’ll find them sold as “research chemicals” from peptide suppliers, but this puts the burden of quality assessment on you. If you go this route, look for companies that provide third-party certificates of analysis (COA) for purity testing. Without independent verification, you’re gambling on what’s actually in the vial.

Why I Use Limitless Life Nootropics

I’ve tested peptides from half a dozen suppliers over the past two years. Some were fine. Some were clearly underdosed or degraded. Limitless has been the most consistent.

What sets them apart: they’re US-based (Arizona), they publish third-party COAs for every batch showing purity testing, and they actually keep peptides in stock. That last part matters more than you’d think. Nothing worse than being mid-cycle and finding out your supplier is backordered for six weeks.

They also have real customer service. I had a shipping issue once and got it resolved same day. Try that with some of the overseas suppliers.

Regardless of source, proper storage matters. Keep reconstituted peptides refrigerated at 36-46°F. Most remain stable for 3-4 weeks once mixed with bacteriostatic water. Never freeze them.

Frequently Asked Questions

Which peptide is best for fat loss?

The CJC-1295/ipamorelin stack produces the most significant fat loss effects due to the synergistic GH release. GH promotes lipolysis (fat burning) while preserving muscle during caloric deficit. Ipamorelin alone is also effective and won’t stimulate appetite like GHRP-6.

Which is safest for beginners?

Ipamorelin. The selectivity means you avoid cortisol, prolactin, and appetite side effects. Sermorelin is a close second with its FDA history and self-limiting mechanism.

Can I stack sermorelin with ipamorelin?

Yes. Sermorelin is a GHRH analog and ipamorelin is a GHRP. They work through different pathways and can be combined for synergistic effects, similar to the CJC-1295/ipamorelin stack.

What’s the difference between CJC-1295 with DAC and without DAC?

Half-life. Without DAC is about 30 minutes; with DAC is 6-8 days. This affects dosing frequency (daily vs. weekly), GH release pattern (pulsatile vs. sustained), and stacking compatibility (no DAC works for stacks; DAC does not).

How long until I see results?

Sleep improvements typically appear within 1-2 weeks. Energy and recovery improvements by weeks 2-4. Visible body composition changes usually take 8-12 weeks of consistent use.

Do I need to cycle these peptides?

Opinions vary. Many practitioners recommend 5 days on, 2 days off to prevent receptor adaptation. Others allow continuous use, particularly with sermorelin. Cycles of 8-16 weeks followed by 4-8 weeks off are common for the more potent options.

Will these show up on a drug test?

Standard employment drug tests do not screen for peptides. However, WADA-regulated athletic testing does. All growth hormone secretagogues are prohibited at all times under WADA rules.

Can women use these peptides?

Yes. All three are used by women, and sermorelin in particular has been studied in perimenopausal and menopausal women. Dosing is typically similar or slightly lower than male protocols.

Bottom Line

After testing all three peptides myself, here’s my honest assessment:

If you’re new to peptides, start with ipamorelin. The clean side effect profile makes it ideal for understanding how your body responds to enhanced GH without confounding variables. Sleep improvements alone make it worthwhile.

If you want the safest option with the most data, go with sermorelin. The FDA history means something. The clinical trials exist. The mechanism is self-limiting. You’re not going to accidentally overdo it.

If you want maximum results, the CJC-1295 (no DAC) + ipamorelin stack is the gold standard. The synergy between GHRH and GHRP pathways produces effects neither peptide achieves alone. This is what most experienced peptide users settle on.

If convenience is paramount, CJC-1295 with DAC offers weekly dosing. But understand you’re trading pulsatile release patterns for convenience, and the regulatory future is uncertain.

The peptide world continues to evolve. New compounds emerge. Regulations shift. What I recommend today might change as evidence accumulates. But the fundamental mechanisms are well-understood, and for most people pursuing better sleep, body composition, recovery, and overall vitality, these three peptides (or combinations thereof) remain the go-to options.

Related: GHK-Cu Peptide Complete Guide: Benefits, Dosage, & Everything You Need to Know

Last updated: December 2025. This article is for informational purposes only and does not constitute medical advice. These peptides are sold as research chemicals and are not FDA-approved for human therapeutic use (except sermorelin’s historical approval for pediatric GH deficiency). Consult a healthcare provider before using any peptide.